HealthyDirect · Growth
Tata Nifty MidSmall Healthcare Index Fund
- NAV
- 15.1181
- 15 Sept 2026
- 1Y
- +13.9%
- Trailing CAGR
- AUM
- ₹207.04 Cr
- 31 Aug 2026
- Volatility
- Medium
- 15.8% annualized
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+13.9%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+18.6%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+25.0%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +18.6%
- Calendar-day CAGR
- Excess 1Y
- +8.6%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 10 days
- 35 recovered episodes
- Longest recovery
- 137 days
- Trough to prior peak
- Current spell
- 7 days
- Days below latest peak
- Time below peak
- +86%
- NAV observations
7 Jan 2025 – 15 Jul 2025
Trough 28 Feb 2025 · recovered in 137 days
-17.5%
29 Jul 2025 – 5 May 2026
Trough 23 Mar 2026 · recovered in 43 days
-11.0%
6 Nov 2024 – 19 Dec 2024
Trough 13 Nov 2024 · recovered in 36 days
-6.0%
15 Oct 2024 – 6 Nov 2024
Trough 23 Oct 2024 · recovered in 14 days
-5.1%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
53
Vs category
100
Consistency
75
Risk-adjusted
67
Drawdown
56
Mean
70
Portfolio
31 Aug 2026 · 31 holdings · top 10 are 60.0%.
- Top 5
- 39.1%
- Top 10
- 60.0%
- Largest holding
- 11.2%
- Effective holdings
- 20.0
Laurus Labs Ltd
Healthcare
11.2%
Lupin Ltd
Healthcare
8.0%
Aurobindo Pharma Ltd
Healthcare
7.2%
Fortis Healthcare Ltd
Healthcare
7.1%
Glenmark Pharmaceuticals Ltd
Healthcare
5.6%
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Healthy
Engine status
Healthy
Doing its job
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 75% of rolling 1-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
Worth investigating
Same-category peers with enough history to inspect beside this fund.
Edelweiss CRISIL IBX AAA Financial Services Bond - Jan 2028 Index Fund
Edelweiss Mutual Fund
- 1Y
- +6.2%
- 3Y
- n/a
- Vol
- 0.9%
- Max DD
- -0.5%
- Sharpe
- 2.48
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
Kotak CRISIL-IBX Financial Services 3-6 Months Debt Index Fund
Kotak Mahindra Mutual Fund
- 1Y
- +6.8%
- 3Y
- n/a
- Vol
- 0.4%
- Max DD
- -0.1%
- Sharpe
- 4.66
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
Nippon India Nifty India Manufacturing Index Fund
Nippon India Mutual Fund
- 1Y
- +4.4%
- 3Y
- n/a
- Vol
- 15.1%
- Max DD
- -12.1%
- Sharpe
- 0.32
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
ICICI Prudential Nifty Auto Index Fund
ICICI Prudential Mutual Fund
- 1Y
- +0.7%
- 3Y
- +18.2%
- Vol
- 17.9%
- Max DD
- -28.3%
- Sharpe
- 0.91
- 3Y win
- +100%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Kotak Nifty Next 50 Index Fund
Kotak Mahindra Mutual Fund
- 1Y
- +3.1%
- 3Y
- +15.7%
- Vol
- 17.5%
- Max DD
- -26.3%
- Sharpe
- 0.59
- 3Y win
- +100%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown